A Study in Patients With Advanced or Metastatic Cancer

Clinical trial NCT01115751 · COMPLETED

Trial details

NCT number: NCT01115751
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastases, Neoplasm

Start date: 2010-03-01
Primary completion: 2012-07-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.